Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $9.3 million.

  • Silo Pharma's Shares Outstanding (Weighted Average) rose 11691.49% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 11691.49%. This contributed to the annual value of $3.7 million for FY2024, which is 1949.8% up from last year.
  • Silo Pharma's Shares Outstanding (Weighted Average) amounted to $9.3 million in Q3 2025, which was up 11691.49% from $6.3 million recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's Shares Outstanding (Weighted Average) ranged from a high of $96.9 million in Q2 2021 and a low of $1.9 million during Q4 2021
  • Over the past 5 years, Silo Pharma's median Shares Outstanding (Weighted Average) value was $3.1 million (recorded in 2023), while the average stood at $12.7 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 26070.67% in 2021, then crashed by 9794.76% in 2022.
  • Silo Pharma's Shares Outstanding (Weighted Average) (Quarter) stood at $1.9 million in 2021, then grew by 20.39% to $2.3 million in 2022, then skyrocketed by 34.83% to $3.1 million in 2023, then grew by 19.5% to $3.7 million in 2024, then surged by 153.54% to $9.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $9.3 million for Q3 2025, versus $6.3 million for Q2 2025 and $4.5 million for Q1 2025.